edoxaban: Clinical Trials

8 trials of edoxaban, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 active not recruiting, 1 unknown. 8 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 18Completed 6, Active not recruiting 1, Unknown 1

Follow edoxaban: new trials by email Literature Review of edoxaban trials Research Report on edoxaban

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial to Evaluate the Effect of Grapefruit Juice on the PK/PD of Edoxaban
Edoxaban 60 MG [Lixiana], Edoxaban 60 MG [Lixiana] + Grapefruit Juice - Healthy
Phase 1Active not recruitingHyewon Chung142025-09-022025-09-16
Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant
VMX-C001, Placebo, Rivaroxaban 20 mg Oral Tablet - Coagulation Disorder
Phase 1CompletedVarmX B.V.402024-02-212026-09-09
PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers
Tegoprazan 50mg, Edoxaban 60mg, Apixaban 5mg - Healthy
Phase 1CompletedHK inno.N Corporation872023-03-062023-12-11
Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects
Apixaban 5 MG Tab, Dabigatran 150 MG Tab, Edoxaban 60Mg Tab - Anticoagulant Therapy
Phase 1UnknownDoasense GmbH242022-07-012022-08-08
Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects
VMX-C001, Placebo, Apixaban - Coagulation Disorder
Phase 1CompletedVarmX B.V.1052021-10-292023-06-02
A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa
Andexanet alfa (Gen 1 Process 2), Apixaban 5 MG, Rivaroxaban 20 MG - Bleeding
Phase 1CompletedPortola Pharmaceuticals1532017-02-262023-08-08
Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study
Edoxaban low dose, Edoxaban high dose - Deep Vein Thrombosis, Venous Thromboembolism
Phase 1CompletedDaiichi Sankyo662014-11-052023-10-11
A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation
60mg edoxaban, 180mg edoxaban, 50 IU/kg Beriplex P/N - Bleeding
Phase 1CompletedDaiichi Sankyo1102013-10-012019-02-12

Conditions studied

Hemorrhage (2)  ·  Hemostatic Disorders (2)  ·  Thrombosis (1)  ·  Venous Thromboembolism (1)  ·  Venous Thrombosis (1)

Sponsors

Daiichi Sankyo (2)  ·  VarmX B.V. (2)  ·  Doasense GmbH (1)  ·  HK inno.N Corporation (1)  ·  Hyewon Chung (1)  ·  Portola Pharmaceuticals (1)

Countries

United States (3)  ·  Netherlands (2)  ·  South Korea (2)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Italy (1)  ·  Lebanon (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Armin Schultz, MD (1)  ·  Min-Gul Kim (1)

Results publications

PMID 25403645

NIH funding

2015 (1), 2023 (1)